Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 3
2000 4
2001 8
2002 3
2003 2
2004 5
2005 1
2006 7
2007 5
2008 8
2009 10
2010 9
2011 2
2013 6
2014 9
2015 4
2016 8
2017 10
2018 11
2019 6
2020 21
2021 26
2022 22
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Patient Safety in the World.
Dhingra-Kumar N, Brusaferro S, Arnoldo L. Dhingra-Kumar N, et al. Among authors: brusaferro s. 2020 Dec 15. In: Donaldson L, Ricciardi W, Sheridan S, Tartaglia R, editors. Textbook of Patient Safety and Clinical Risk Management [Internet]. Cham (CH): Springer; 2021. Chapter 8. 2020 Dec 15. In: Donaldson L, Ricciardi W, Sheridan S, Tartaglia R, editors. Textbook of Patient Safety and Clinical Risk Management [Internet]. Cham (CH): Springer; 2021. Chapter 8. PMID: 36315756 Free Books & Documents. Review.
[Cardiovascular screening].
Pellizzari B, Siddu A, Ferro A, Colonna M, Mantovani W, Valsecchi M, Marensi L, Moro A, Brusaferro S, Cinquetti S. Pellizzari B, et al. Among authors: brusaferro s. Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 2):73-7. Epidemiol Prev. 2014. PMID: 25759348 Free article. Italian.
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19.
Mateo-Urdiales A, Sacco C, Petrone D, Bella A, Riccardo F, Del Manso M, Bressi M, Siddu A, Brusaferro S, Palamara AT, Rezza G, Pezzotti P, Fabiani M; Italian National COVID-19 Integrated Surveillance System and the Italian COVID-19 vaccines registry. Mateo-Urdiales A, et al. Among authors: brusaferro s. JAMA Netw Open. 2023 Oct 2;6(10):e2336854. doi: 10.1001/jamanetworkopen.2023.36854. JAMA Netw Open. 2023. PMID: 37792377 Free PMC article.
Harmonizing and supporting infection control training in Europe.
Brusaferro S, Arnoldo L, Cattani G, Fabbro E, Cookson B, Gallagher R, Hartemann P, Holt J, Kalenic S, Popp W, Privitera G, Prikazsky V, Velasco C, Suetens C, Varela Santos C. Brusaferro S, et al. J Hosp Infect. 2015 Apr;89(4):351-6. doi: 10.1016/j.jhin.2014.12.005. Epub 2015 Jan 7. J Hosp Infect. 2015. PMID: 25777079 Free article. Review.
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022.
Stefanelli P, Trentini F, Petrone D, Mammone A, Ambrosio L, Manica M, Guzzetta G, d'Andrea V, Marziano V, Zardini A, Molina Grane' C, Ajelli M, Di Martino A, Riccardo F, Bella A, Sane Schepisi M, Maraglino F, Poletti P, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Merler S; Genomic SARS–CoV–2 National Surveillance Working Group; Italian Integrated Surveillance of COVID–19 Study Group; Italian Integrated Surveillance of COVID-19 Study Group; Genomic SARS-CoV-2 National Surveillance Working Group. Stefanelli P, et al. Among authors: brusaferro s. Euro Surveill. 2022 Nov;27(45):2200125. doi: 10.2807/1560-7917.ES.2022.27.45.2200125. Euro Surveill. 2022. PMID: 36367013 Free PMC article.
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022.
Fabiani M, Mateo-Urdiales A, Sacco C, Fotakis EA, Rota MC, Petrone D, Bressi M, Del Manso M, Siddu A, Fedele G, Stefanelli P, Bella A, Riccardo F, Palamara AT, Rezza G, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: brusaferro s. Euro Surveill. 2023 Feb;28(8):2300105. doi: 10.2807/1560-7917.ES.2023.28.8.2300105. Euro Surveill. 2023. PMID: 36820640 Free PMC article.
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023.
Fabiani M, Mateo-Urdiales A, Sacco C, Rota MC, Fotakis EA, Petrone D, Del Manso M, Siddu A, Stefanelli P, Bella A, Riccardo F, Rezza G, Palamara AT, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: brusaferro s. Euro Surveill. 2023 Aug;28(32):2300397. doi: 10.2807/1560-7917.ES.2023.28.32.2300397. Euro Surveill. 2023. PMID: 37561053 Free PMC article.
Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study.
Fedele G, Trentini F, Schiavoni I, Abrignani S, Antonelli G, Baldo V, Baldovin T, Bandera A, Bonura F, Clerici P, De Paschale M, Fortunato F, Gori A, Grifantini R, Icardi G, Lazzarotto T, Lodi V, Mastroianni CM, Orsi A, Prato R, Restivo V, Carsetti R, Piano Mortari E, Leone P, Olivetta E, Fiore S, Di Martino A, Brusaferro S, Merler S, Palamara AT, Stefanelli P. Fedele G, et al. Among authors: brusaferro s. Front Immunol. 2022 Oct 31;13:1021396. doi: 10.3389/fimmu.2022.1021396. eCollection 2022. Front Immunol. 2022. PMID: 36389704 Free PMC article.
190 results